Publicações Científicas 2024 - Março

1. Pires RC, Gama RR, da Silveira Júnior PS, Teixeira FM, Santos CR, de Castro Capuzzo R. Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center. Eur Arch Otorhinolaryngol. 2024;281(1):351-7. 10.1007/s00405-023-08180-w.

2. Monteiro MR, Nunes NCC, Junior A, Fêde ABS, Bretas GO, Souza CP, et al. Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast Cancer (Dove Med Press). 2024;16:51-70. 10.2147/bctt.S448191.

3. Reis MT, Matsushita M, Santos W, de Lima MA, Guimarães DP, Reis RM. Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancer. Surgical Experimental Pathology. 2024;7(1):1. 10.1186/s42047-024-00144-6.

4. Pirola WE, Barroso EM, Gama RR, dos Santos Neto MF, Teodoro VA, da Silva Tozzo FCB, et al. Association between periodontal disease and breast cancer: systematic review and meta-analysis. Revista Eletrônica Acervo Saúde. 2024;24(2):e15386-e. 10.25248/reas.e15386.2024.

5. Casali BC, Baptista MP, Pachane BC, Cortez AA, Altei WF, Selistre-de-Araújo HS. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity. Biochem Biophys Rep. 2024;38:101686. 10.1016/j.bbrep.2024.101686.

6. Buralli R, Ribeiro A, Cremonese C, Vineis P, Meyer A. Cancer mortality and premature deaths among hairdressers in Brazil. Environ Res. 2024;244:117942. 10.1016/j.envres.2023.117942.

7. Gouveia AG, Viani GA, Bratti VF, Marta GN, Hanna SA, Jacinto AA, et al. Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion plan. J Cancer Policy. 2024;39:100459. 10.1016/j.jcpo.2023.100459.

8. Paiva CE, Paiva BSR. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. Oncologist. 2024;29(2):e296-e7. 10.1093/oncolo/oyad284.

9. Aguiar Freitas AJ, Nunes CR, Mano MS, Causin RL, Calfa S, de Oliveira MA, et al. Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trial. Future Oncol. 2024;20(1):25-38. 10.2217/fon-2023-0886.

10. Arruda do Espirito Santo P, Meine GC, Baraldo S, Barbosa EC. Cold endoscopic mucosal resection versus cold snare polypectomy for colorectal lesions: a systematic review and meta-analysis of randomized controlled trials. Endoscopy. 2024. 10.1055/a-2275-5349.

11. Syrjänen K, Eskelinen M, Meklin J, Hendolin P, Eskelinen M, Suovaniemi O. Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB). Anticancer Res. 2024;44(4):1513-23. 10.21873/anticanres.16948.

12. Bednar EM, Paiz KA, Lu KH, Soares Dias De Souza AP, Oliveira G, Andrade C, et al. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico. Int J Gynecol Cancer. 2024. 10.1136/ijgc-2023-005190.

13. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. The Diagnostic Accuracy (DA) of ColonView Fecal Immunochemical Test (FIT) in Detecting Colorectal Adenoma (CRA) Can Be Improved by the Diagnostic Models (DM) that Include Triage and Risk Features of CRA. Anticancer Res. 2024;44(1):173-84. 10.21873/anticanres.16800.

14. Scuglia M, Frazão LP, Miranda A, Martins A, Barbosa-Sequeira J, Coimbra D, et al. Diaphragmatic hernia repair porcine model to compare the performance of biodegradable membranes against Gore-Tex(®). Pediatr Surg Int. 2024;40(1):7. 10.1007/s00383-023-05584-x.

15. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 2024;35(3):523-9. 10.1007/s10552-023-01812-w.

16. Wood A, Pereira A, Araújo E, Ferigatto J, Buexm L, Barroso E, et al. Evaluation of the Impact of Oral Health on the Daily Activities of Users of the National Health System. Int J Environ Res Public Health. 2024;21(1). 10.3390/ijerph21010092.

17. Vieira IA, Viola GD, Pezzi EH, Kowalski TW, Fernandes BV, Andreis TF, et al. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas. Genet Mol Biol. 2024;46(3 Suppl 1):e20230133. 10.1590/1678-4685-gmb-2023-0133.

18. Vieira R, Paulinelli RR, de Oliveira-Junior I. Extreme oncoplasty: past, present and future. Front Oncol. 2024;13:1215284. 10.3389/fonc.2023.1215284.

19. Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, et al. First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. J Clin Oncol. 2024:Jco2301601. 10.1200/jco.23.01601.

20. Palavani LB, Silva GM, Borges P, Ferreira MY, Sousa MP, Leite M, et al. Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis. J Neurooncol. 2024. 10.1007/s11060-024-04621-6.

21. Vieira IA, Pezzi EH, Bandeira IC, Reis LB, de Araújo Rocha YM, Fernandes BV, et al. Functional pri-miR-34b/c rs4938723 and KRAS 3’UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome? Gene. 2024;898:148069. 10.1016/j.gene.2023.148069.

22. De Marchi P, Leal LF, da Silva LS, Cavagna RO, da Silva FAF, da Silva VD, et al. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Transl Oncol. 2024;39:101818. 10.1016/j.tranon.2023.101818.

23. Pereira-Vieira J, Weber DD, Silva S, Barbosa-Matos C, Granja S, Reis RM, et al. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. J Pharmaceutics. 2024;16(4):442. 10.3390/pharmaceutics16040442.

24. Paiva BSR, Mingardi M, de Almeida LF, de Camargos MG, Valentino TCO, Julião M, et al. Go Wish card game-exploring end-of-life wishes of patients in oncology palliative care: a qualitative study. Ann Palliat Med. 2024;13(1):31-41. 10.21037/apm-23-381.

25. Custódio IDD, Nunes FSM, Lima MTM, Carvalho KP, Machado AM, Lajolo PP, et al. Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy. Clinics (Sao Paulo). 2024;79:100324. 10.1016/j.clinsp.2024.100324.

26. Campacci N, Grasel RS, Galvão HCR, Garcia LF, Ribeiro PC, Pereira K, et al. The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing? Front Psychol. 2024;15:1306388. 10.3389/fpsyg.2024.1306388.

27. Sorroche BP, Miranda KC, Beltrami CM, Arantes L, Kowalski LP, Marchi FA, et al. HOXA1 3’UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers (Basel). 2024;16(5). 10.3390/cancers16050874.

28. Teixeira RJ, de Souza VG, Sorroche BP, Paes VG, Zambuzi-Roberto FA, Pereira CAD, et al. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy. Melanoma Res. 2024. 10.1097/cmr.0000000000000958.

29. Vianna FSL, Neves LL, Testa R, Nassar AP, Jr., Peres JHF, da Silva RÁ J, et al. Impact of the COVID-19 Pandemic on the Outcomes of Patients Undergoing Oncological Surgeries: CORONAL Study. Ann Surg Oncol. 2024. 10.1245/s10434-024-15152-9.

30. Chavan R, Baraldo S, Rajput S. Inclusion of Patients With Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention. Gastroenterology. 2024;166(1):215. 10.1053/j.gastro.2023.05.011.

31. Vieira TDS, Freitas FV, Silva Neto LCB, Borçoi AR, Barbosa WM, Olinda AS, et al. An industrialized diet as a determinant of methylation in the 1F region of the NR3C1 gene promoter. Frontiers in Nutrition. 2024;11:1168715. 10.3389/fnut.2024.1168715.

32. Ferreira J, Afonso J, Longatto-Filho A, Roque S, Carneiro A, Vila I, et al. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2024;99:10-8. 10.1016/j.avsg.2023.09.094.

33. Riedmeier M, Antonini SRR, Brandalise S, Costa T, Daiggi CM, de Figueiredo BC, et al. International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects. Eur J Endocrinol. 2024;190(4):G15-g24. 10.1093/ejendo/lvae038.

34. Cappellano AM, Dassi N, Mançano BM, Epelman S, Almeida DB, Cavalheiro S, et al. Intracranial non-germinomatous germ cell tumors in children and adolescents: how can the experience from an uppermiddle-income country contribute to the worldwide effort to improve outcomes? Front Oncol. 2024;14:1308128. 10.3389/fonc.2024.1308128.

35. de Arruda JAA, Oliveira SR, Heimlich FV, de Amorim-Santos BM, Schneider AH, de Sena A, et al. Kinetics of neutrophil extracellular traps and cytokines in oral mucositis and Candida infection. Oral Dis. 2024. 10.1111/odi.14857.

36. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study. Int J Cancer. 2024. 10.1002/ijc.34861.

37. Paiva CE, Zonta MPM, Granero RC, Guimarães VS, Pimenta LM, Teixeira GR, et al. The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients. Cancers (Basel). 2024;16(2). 10.3390/cancers16020339.

38. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 2024:100500. 10.1016/j.xgen.2024.100500.

39. Stelet VN, Romero M, Cita RF, Binato R, Abdelhay E. A novel HLA-C*02:10 variant, HLA-C*02:10:09, identified in a healthy individual from Brazil. Hla. 2024;103(2):e15410. 10.1111/tan.15410.

40. Junior JNA, Preto DD, Lazarini M, de Lima MA, Bonatelli M, Berardinelli GN, et al. PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site. Int J Clin Oncol. 2024. 10.1007/s10147-024-02494-3.

41. Ferreira J, Longatto-Filho A, Dionísio A, Correia-Neves M, Cunha P, Mansilha A. Peri-Carotid Adipose Tissue and Atherosclerosis at Carotid Bifurcation. J Cardiovasc Dev Dis. 2024;11(2). 10.3390/jcdd11020058.

42. Fontes MS, de Almeida DVP, Cárcano F, Lages P, Dienstmann R. Precision medicine for urothelial carcinoma: An international perspective. Urol Oncol. 2024. 10.1016/j.urolonc.2023.11.008.

43. McNeil MJ, Garcia Quintero X, Gonzalez M, Zheng Y, Ugaz Olivares C, Morales R, et al. Preventing and Treating Pain and Anxiety during Needle-Based Procedures in Children with Cancer in Low- and Middle-Income Countries. Cancers (Basel). 2024;16(5). 10.3390/cancers16051025.

44. Barbosa EC, Espírito Santo PA, Baraldo S, Meine GC. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. 2024. 10.1016/j.bja.2024.02.005.

45. Arias AV, Lintner-Rivera M, Shafi NI, Abbas Q, Abdelhafeez AH, Ali M, et al. A research definition and framework for acute paediatric critical illness across resource-variable settings: a modified Delphi consensus. Lancet Glob Health. 2024;12(2):e331-e40. 10.1016/s2214-109x(23)00537-5.

46. Ubinha ACF, Pedrão PG, Tadini AC, Schmidt RL, Santos MHD, Andrade C, et al. The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature. Cancers (Basel). 2024;16(4). 10.3390/cancers16040817.

47. Vázquez-Iglesias L, Stanfoca Casagrande GM, García-Lojo D, Ferro Leal L, Ngo TA, Pérez-Juste J, et al. SERS sensing for cancer biomarker: Approaches and directions. Bioact Mater. 2024;34:248-68. 10.1016/j.bioactmat.2023.12.018.

48. Ferreira MY, Thomaz de Assis EB, Batista S, Palavani LB, Verly G, Corrêa EM, et al. Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis. World Neurosurg. 2024. 10.1016/j.wneu.2024.01.006.

49. Oliveira AGS, Rocha MA, de Azevedo LS, Coelho ATM, Chagas RCR, Santos HB, et al. Tapirira guianensis is Selectively Cytotoxic, Induces Apoptosis to the Glioblastoma and Decreases Tumor Growth and Angiogenesis in vivo. Planta Med. 2024;90(1):13-24. 10.1055/a-2181-2569.

50. Carvalho BF, Gomez GVB, Carron J, Macedo LT, Gonçalves GM, Vazquez VL, et al. TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma. Int J Mol Sci. 2024;25(5). 10.3390/ijms25052868.

51. Palavani LB, Ferreira MY, Borges P, Bandeira L, da Silva Semione G, Almeida MV, et al. Ultrasound-Guided Resection of High-Grade Gliomas: A Single-Arm Meta-Analysis. World Neurosurg. 2024;186:17-26. 10.1016/j.wneu.2024.03.033.

52. Garcia ALH, de Souza MR, Picinini J, Soares S, Rohr P, Linden R, et al. Unraveling gene expression and genetic instability in dental fluorosis: Investigating the impact of chronic fluoride exposure. Sci Total Environ. 2024;906:167393. 10.1016/j.scitotenv.2023.167393.

53. Wang W, Kumm ZT, Ho C, Zanesco-Fontes I, Texiera G, Reis RM, et al. Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. Neurooncol Adv. 2024;6(1):vdad140. 10.1093/noajnl/vdad140.

54. Arantes L, Silva-Oliveira RJ, de Carvalho AC, Melendez ME, Sorroche BP, de Jesus Teixeira R, et al. Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment. Head Neck. 2024;46(3):461-72. 10.1002/hed.27602.

55. Straus Takahashi M, Gustavo Ieiri Yamanari M, Henrique de Marqui Moraes P, Iglesias Lopes R, Chammas MC. Vesicoureteral reflux by contrast ultrasound, comparison with voiding and retrograde urethrocystography: A prospective accuracy study. J Pediatr Urol. 2024;20(1):133.e1-.e9. 10.1016/j.jpurol.2023.10.014.

56. Trevizan FB, Paiva CE, de Almeida LF, de Oliveira MA, Bruera E, Paiva BSR. When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2024;22(2):387-95. 10.1017/s1478951523001517.